TrialBMC nephrology2019
A prospective study of daclatasvir and sofosbuvir in chronic HCV-infected kidney transplant recipients.
Michael Duerr et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
TrialBMC nephrology2019
Michael Duerr et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.